State Street’s Oramed Pharmaceuticals ORMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-66,451
Closed -$150K 4350
2025
Q2
$150K Buy
66,451
+1,235
+2% +$2.72K ﹤0.01% 3896
2025
Q1
$140K Buy
65,216
+4,398
+7% +$10.1K ﹤0.01% 3899
2024
Q4
$147K Buy
60,818
+762
+1% +$1.81K ﹤0.01% 3913
2024
Q3
$147K Buy
60,056
+796
+1% +$1.94K ﹤0.01% 3893
2024
Q2
$152K Buy
59,260
+1,128
+2% +$2.68K ﹤0.01% 3895
2024
Q1
$170K Buy
58,132
+158
+0.3% +$442 ﹤0.01% 3910
2023
Q4
$134K Buy
57,974
+1,160
+2% +$2.48K ﹤0.01% 3988
2023
Q3
$148K Buy
56,814
+1,512
+3% +$4.76K ﹤0.01% 4008
2023
Q2
$198K Buy
55,302
+1,436
+3% +$4.6K ﹤0.01% 4015
2023
Q1
$117K Buy
53,866
+2,873
+6% +$9.13K ﹤0.01% 4268
2022
Q4
$613K Buy
50,993
+4,001
+9% +$31.1K ﹤0.01% 3694
2022
Q3
$305K Buy
46,992
+983
+2% +$7.96K ﹤0.01% 3965
2022
Q2
$211K Sell
46,009
-491,661
-91% -$2.63M ﹤0.01% 4173
2022
Q1
$4.65M Buy
537,670
+25,424
+5% +$260K ﹤0.01% 3219
2021
Q4
$7.32M Buy
512,246
+24,247
+5% +$507K ﹤0.01% 3064
2021
Q3
$10.7M Buy
487,999
+136,079
+39% +$2.32M ﹤0.01% 2852
2021
Q2
$4.71M Buy
+351,920
New +$4.03M ﹤0.01% 3280

Other funds holding ORMP